FDA approves Keytruda as adjuvant treatment for kidney cancer – Fox News

The cancer immunotherapy drug Keytruda (pembrolizumab), was approved Thursday by the U.S. Food and Drug Administration (FDA) to help in the fight against renal cell carcinoma (RCC), according to a ne… [+3977 chars]